TELA Bio, Inc. announced revenue guidance for the full year 2022. For the year, the company expected revenue to be in range from $40 million to $45 million, reflecting growth of 36% to 53% over full year 2021.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.575 USD | -2.36% | -4.89% | -16.24% |
Jun. 04 | TELA Bio, Inc. Appoints Jeffrey Blizard to its Board of Directors | CI |
May. 20 | TELA Bio, Inc. Appoints Greg Firestone as Chief Commercial Officer | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.24% | 141M | |
-6.63% | 180B | |
+0.04% | 109B | |
-2.85% | 68.93B | |
-3.18% | 46.41B | |
+12.61% | 45.43B | |
+7.38% | 43.26B | |
+17.82% | 30.05B | |
+16.10% | 25.19B | |
-7.14% | 23.34B |
- Stock Market
- Equities
- TELA Stock
- News TELA Bio, Inc.
- TELA Bio, Inc. Announces Revenue Guidance for the Full Year 2022